SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/72FAA1A354BB9350259FAF1A074B31008CF61CB6812A95EBE8034BB6054A85C9AF2E927870A665FC369B24454E3059AE>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/72FAA1A354BB9350259FAF1A074B31008CF61CB6812A95EBE8034BB6054A85C9AF2E927870A665FC369B24454E3059AE
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/72FAA1A354BB9350259FAF1A074B31008CF61CB6812A95EBE8034BB6054A85C9AF2E927870A665FC369B24454E3059AE
http://www.w3.org/2000/01/rdf-schema#comment
"Data show that KIR activation and HLA expression density are critical determinants for the efficacy of rituximab treatment."
xsd:string
http://purl.uniprot.org/uniprot/#_423D4FD23B91319B438B94EC38A97CD3F9D8D8D9705EADACBEC816A35534EB848729502DD7A7CAF8A1548FD76DCFFD02
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/72FAA1A354BB9350259FAF1A074B31008CF61CB6812A95EBE8034BB6054A85C9AF2E927870A665FC369B24454E3059AE
http://purl.uniprot.org/uniprot/K7R1Q7
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/72FAA1A354BB9350259FAF1A074B31008CF61CB6812A95EBE8034BB6054A85C9AF2E927870A665FC369B24454E3059AE
http://purl.uniprot.org/uniprot/#_K7R1Q7-mappedCitation-20056126
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/72FAA1A354BB9350259FAF1A074B31008CF61CB6812A95EBE8034BB6054A85C9AF2E927870A665FC369B24454E3059AE